RUBBISH, what are you banging on about.
JP clearly states a reluctance to take it further than getting the P3 tick from the FDA, as I mentioned once before there is a big
difference between getting the FDA P3 tick then having the infrastructure to get it to market which clearly NEU do not have and
seem very reluctant to build..................understandably so and I am in complete agreement.
AGAIN, this is all about building the best value before being taken out
Ann: NEU continues PMS P3 preparations after positive FDA meeting, page-56
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |